NCT00542035View on ClinicalTrials.gov

A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction

PHASE2CompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

November 11, 2007

Primary Completion Date

February 11, 2008

Study Completion Date

February 11, 2008

Conditions
Dental Pain
Interventions
DRUG

ARRY-371797, p38 inhibitor; oral

dose 1, dose 2

DRUG

Placebo; oral

dose 1, dose 2

DRUG

Placebo; oral

dose 1

DRUG

ARRY-371797, p38 inhibitor; oral

dose 2

Trial Locations (2)

78666

SCIREX Research Center, San Marcos

84117

SCIREX Research Center, Salt Lake City

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT00542035 - A Study of ARRY-371797 in Subjects Undergoing Third Molar Extraction | Biotech Hunter | Biotech Hunter